AstraZeneca Q2 2026 Earnings
Rev. $15.38B (est $15.42B) Core EPS $2.63 (est $2.48) Reconfirms Rev, Core EPS Guidance For FY On Track To Deliver Ambition Of $80B In Rev In 2030
Story updates
06:14:22 AM UTC
SquawkNews
AstraZeneca Q2 2026 Earnings
Rev. $15.38B (est $15.42B) Core EPS $2.63 (est $2.48) Reconfirms Rev, Core EPS Guidance For FY On Track To Deliver Ambition Of $80B In Rev In 2030